Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to $2.2 billion.

  • Pediatrix Medical's Liabilities and Shareholders Equity rose 589.98% to $2.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $8.4 billion, marking a year-over-year decrease of 14.79%. This contributed to the annual value of $2.2 billion for FY2024, which is 302.32% down from last year.
  • Latest data reveals that Pediatrix Medical reported Liabilities and Shareholders Equity of $2.2 billion as of Q3 2025, which was up 589.98% from $2.1 billion recorded in Q2 2025.
  • In the past 5 years, Pediatrix Medical's Liabilities and Shareholders Equity ranged from a high of $2.7 billion in Q4 2021 and a low of $2.0 billion during Q1 2025
  • Its 5-year average for Liabilities and Shareholders Equity is $2.3 billion, with a median of $2.3 billion in 2023.
  • Per our database at Business Quant, Pediatrix Medical's Liabilities and Shareholders Equity tumbled by 4250.14% in 2021 and then surged by 589.98% in 2025.
  • Pediatrix Medical's Liabilities and Shareholders Equity (Quarter) stood at $2.7 billion in 2021, then fell by 13.76% to $2.3 billion in 2022, then dropped by 5.45% to $2.2 billion in 2023, then fell by 3.02% to $2.2 billion in 2024, then increased by 2.17% to $2.2 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $2.2 billion for Q3 2025, versus $2.1 billion for Q2 2025 and $2.0 billion for Q1 2025.